New device expands AtriCure’s market opportunity in post-operative pain management while addressing a significant unmet clinical need Recently cleared under an FDA 510(k), the cryoXT device is ...
When surgeons remove an aggressive bone tumor from the pelvis, saving a patient's life can mean sacrificing a large portion of the spine and hip. Putting that fragile structure back together in a way ...
AtriCure, Inc. ( Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results